Andrew Limper, MD, on the Effectiveness of Antifibrotics for IPF
In this podcast, Andrew Limper, MD, discusses his latest research on 2 antifibrotic drugs for the treatment of idiopathic pulmonary fibrosis, which was recently published by the American Thoracic Society. More at: www.consultant360.com/pulmonology.